Clinical Trials

Randomized Phase III Trial of Haploidentical HCT with or without an Add back Strategy of HSV-Tk Donor Lymphocytes in Patients with High Risk Acute Leukemia


Study ID
MolMed TK008

NCT Number
NCT00914628 (Click on the NCT number for more information about the trial)

Research Study Number
00003722

Principle Investigator
Dr. Michele Donato

Phase
III

Sponsor
MolMed


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now